Buscar
-
Use of IV Iron and Risk of Anaphylaxis: A Multinational Observational Post-Authorisation Safety Study in Europe
(Pharmacoepidemiology and Drug Safety, 2021-06-28)Article de revueLibre acceso -
Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(American Journal of Cardiovascular Drugs, 2021-12-21)Article de revue -
Patients with stable coronary artery disease and type 2 diabetes but without prior myocardial infarction or stroke and THEMIS-like patients: real-world prevalence and risk of major outcomes from the SNDS French nationwide claims database
(Cardiovascular Diabetology. vol. 20, n° 1, pp. 229, 2021-11-25)Article de revueLibre acceso -
Treatment resistant depression incidence and prevalence using the French nationwide claims database
(Pharmacoepidemiology and Drug Safety. vol. 30, n° 2, pp. 169–177, 2021-02)Article de revue -
Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015)
(Frontiers in Pharmacology. vol. 12, pp. 682890, 2021-11-03)Article de revueLibre acceso -
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data
(BMC Medical Research Methodology. vol. 21, n° 1, pp. 95, 2021-05-01)Article de revueLibre acceso